Creative Planning Invests $91,000 in Paragon 28, Inc. (NYSE:FNA)

Creative Planning purchased a new stake in shares of Paragon 28, Inc. (NYSE:FNA) during the 3rd quarter, Holdings Channel reports. The fund purchased 13,682 shares of the company’s stock, valued at approximately $91,000.

Other institutional investors also recently bought and sold shares of the company. Nisa Investment Advisors LLC lifted its holdings in shares of Paragon 28 by 46,660.0% in the 2nd quarter. Nisa Investment Advisors LLC now owns 4,676 shares of the company’s stock worth $32,000 after acquiring an additional 4,666 shares during the last quarter. Levin Capital Strategies L.P. bought a new position in shares of Paragon 28 during the second quarter valued at approximately $68,000. Price T Rowe Associates Inc. MD raised its holdings in shares of Paragon 28 by 16.3% in the first quarter. Price T Rowe Associates Inc. MD now owns 12,622 shares of the company’s stock worth $156,000 after buying an additional 1,766 shares during the period. Hsbc Holdings PLC bought a new stake in shares of Paragon 28 during the 2nd quarter worth approximately $104,000. Finally, SG Americas Securities LLC bought a new position in Paragon 28 in the 3rd quarter valued at $128,000. 63.57% of the stock is currently owned by institutional investors.

Paragon 28 Trading Down 1.7 %

Shares of NYSE FNA opened at $7.50 on Wednesday. Paragon 28, Inc. has a twelve month low of $4.65 and a twelve month high of $14.79. The firm has a market cap of $626.57 million, a PE ratio of -11.05 and a beta of 1.01. The business has a fifty day simple moving average of $6.29 and a two-hundred day simple moving average of $7.20. The company has a quick ratio of 1.70, a current ratio of 3.57 and a debt-to-equity ratio of 0.75.

Analysts Set New Price Targets

A number of analysts have recently issued reports on the stock. Piper Sandler reissued an “overweight” rating and set a $12.00 target price (down from $15.00) on shares of Paragon 28 in a research note on Friday, August 9th. Needham & Company LLC lowered their price objective on shares of Paragon 28 from $14.00 to $11.00 and set a “buy” rating for the company in a research report on Friday, August 9th.

Paragon 28 Company Profile

Paragon 28, Inc develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems.